Proteins and Peptides

25 Apr 2007 Beyond biogenerics: the real threats for therapeutic proteins
25 Apr 2007 Allon Therapeutics confirms oral bioavailability of AL-309
25 Apr 2007 Study Shows Ambrilia's Therapeutic Peptide PCK3145 Has Clinical Activity In Metastatic Prostate Cancer Patients
25 Apr 2007 Protox Doses First Patient In Benign Prostatic Hyperplasia Trial Using PRX302
24 Apr 2007 Hemispherx and Armada Health Care enter Agreement to Launch Alferon N Injection(R) via Specialty Pharmacy Network
21 Apr 2007 Baxter Presents Phase I Inhaled Insulin Study Results at Respiratory Drug Delivery Conference
21 Apr 2007 Cleveland BioLabs Protectan CBLB612 Demonstrates Efficacy in Stimulating Proliferation and Mobilization of Bone Marrow Stem Cells in Primate Model
20 Apr 2007 Aranesp(R) ''145 Study'' Shows No Difference in Survival in Patients with Small-Cell Lung Cancer
19 Apr 2007 Protalix BioTherapeutics, Inc. Receives Approval from the FDA to Initiate a Phase III Clinical Trial of prGCD. Phase III clinical trial may commence shortly
19 Apr 2007 Viragen Announces European Multiferon(R) Licensing Agreement
18 Apr 2007 Dyax Initiates Confirmatory Phase 3 (EDEMA4) Trial for DX-88 for the Treatment of Hereditary Angioedema
18 Apr 2007 DeveloGen and Andromeda, a newly formed wholly-owned subsidiary of Clal Biotechnology Industries, Sign Term Sheet for Asset Purchase Agreement for the DiaPep277(R) Program
18 Apr 2007 Adnexus Therapeutics Announces Presentation at the American Association for Cancer Research (AACR) on Clinical Product Candidate, CT-322
18 Apr 2007 Prevascar Phase II Results
18 Apr 2007 OncoGenex Technologies Announces Phase II Data of OGX-011 in Metastatic
17 Apr 2007 Preclinical Data Show Alfacell's ONCONASE(R) Inhibits Tumor Growth of Non-Small Cell Lung Cancer, Breast Cancer Cells Poster Presented at AACR Annual Meeting
17 Apr 2007 Aranesp(R) Phase 3 Study in Patients with Active Cancer Not Receiving Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual Meeting
15 Apr 2007 Human Genome Sciences Reports Positive Interim Results of Phase 2b Trial of Albuferon(R)
13 Apr 2007 Affymax(R) Announces Results From Phase 2 Clinical Trial of Hematide(TM) for the Treatment of Anemia in Dialysis Patients
13 Apr 2007 Intarcia Therapeutics Announces Final Results From A Phase 2 Study Of Injectable Omega Interferon plus Ribavirin for the Treatment of Hepatitis C Genotype-1
13 Apr 2007 DX-88 for Hereditary Angioedema Meets Primary and Secondary Endpoints in Phase 3 Trial (EDEMA3(R))
12 Apr 2007 Follistim(R) introduced in Japan in a further indication for the treatment of infertility
12 Apr 2007 Nuvelo Announces Publication of NU206 Study Results in Gastroenterology
11 Apr 2007 Stem Cell Therapeutics Corp. Announces Positive Interim Results From its Currently Enrolling Phase IIa Clinical Program for NTx(TM)-265 in Acute Stroke
06 Apr 2007 PEGINTRON(TM) Approved in China for Treating Chronic Hepatitis B

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top